Young researchers from Siberian Federal University (SibFU) along with their colleagues from FRC KSC SB RAS are designing a technology for producing multilayer gilded nanodisks for targeted drug delivery and treating cancer using dip pen nanolithography (DPN).
“Magnetic nanodiscs coated with gold are in high demand in Biology and Medicine. They can be successfully used for magnetically induced apoptosis (the process of programmed cell death) and mechanical destruction of cell membranes. Nanodiscs can be ‘programmed’ to deliver drugs exclusively to diseased organs and tissues, and they can also mechanically destroy target cells (for example, malignant tumor cells). To place the nanodisks into the human body, they need to be ‘dressed’ in a special coating that will reduce the toxicity of our agents, prevent their early degradation in the body and allow them to ‘increase’ the aptamers on them for targeted delivery of medicines. Therefore, the structure of the disks is multi-layered and consists of a ferromagnetic metal coated with gold. Nowadays, a high-vacuum deposition method is used in combination with lithography methods and chemical etching processes to obtain such nanodisks, which determine the shape and size of the final product,” — says Anna Lukjanenko, the assistant of the specialized department of Solid State Physics and Nanotechnology at Siberian Federal University, scientist of Kirensky Institute of Physics SB RAS.
To yield nanoparticles with a large range of sizes and shapes and strict control of their parameters for producing disks for medical needs, university researchers are developing more cost-effective and adaptable technology compared to the current one.
“We want to improve the technology of dip pen nanolithography so that multilayer thin films of metals can be used as substrates. Then, dip pen nanolithography will help us produce precisely those nanodisks which are required by the medical research groups involved in introducing new treatment methods (for example, researchers from Krasnoyarsk State Medical University named after Professor V. F. Voino-Yasenetsky). Also, this method can be implemented in almost any production such as a plant and or a research center,” — the scientist said.
News This Week
There is no vaccine or specific treatment for COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2. Since the outbreak began in late 2019, researchers have been racing to [...]
Corona Virus (COVID 19) Interview with Michael Osterholm an expert in infectious disease epidemiology.
Michael Osterholm is an internationally recognized expert in infectious disease epidemiology. He is Regents Professor, McKnight Presidential Endowed Chair in Public Health, the director of the Center for Infectious Disease Research and Policy [...]
With the new coronavirus spreading from person to person (possibly including from people without symptoms), reaching four continents, and traveling faster than SARS, driving it out of existence is looking increasingly unlikely. It’s still [...]
Wake Forest Institute for Regenerative Medicine (WFIRM) scientists have improved upon the 3D bioprinting technique they developed to engineer skeletal muscle as a potential therapy for replacing diseased or damaged muscle tissue, moving another [...]
An international team of scientists from the University of Southampton, the University of Padova, and the University of Zurich has connected a silicon neuron to a neuron from the rat hippocampus with an artificial [...]
In an insightful 42-minute interview, NMIN’s Scientific Director Dr. Pieter Cullis, a pioneer in liposomal gene and drug delivery, discusses his scientific career with a focus on his contributions to the evolution of [...]
A powerful antibiotic that kills some of the most dangerous drug-resistant bacteria in the world has been discovered using artificial intelligence. The drug works in a different way to existing antibacterials and is the [...]
Artificial intelligence hit a big milestone in January — the first drug designed entirely using artificial intelligence entered human clinical trials. The compound, created by Oxford-based biotech company Exscientia, is aimed at treating obsessive-compulsive [...]
Researchers at the Massachusetts General Hospital (MGH) in the US have uncovered the ‘Achilles’ heel’ of most viruses which plague mankind, and could soon develop a universal vaccine. Vaccine research, development and testing takes [...]
Every age in the history of human civilisation has a signature material, from the Stone Age, to the Bronze and Iron Ages. We might even call today’s information-driven society the Silicon Age. Since the [...]
CRISPR gene-edited immune cells have been injected into three people with advanced cancer without any serious side effects, the first trial of its kind in the US. It is also the first CRISPR cancer [...]
“We’ll have nanobots that… connect our neocortex to a synthetic neocortex in the cloud. Our thinking will be a…. biological and non-biological hybrid.” Ray Kurzweil, TED 2014 UPDATE - February 9 2020 Since [...]
Frank Boehm (NanoApps Medical Inc. founder) and Amanda Scott (NA CEO) join NanoApps Athletics Inc. NanoApps Athletics Inc proposes a unique synergistic biochemical/nanomedical strategy for the expedited repair and healing of Achilles tendon micro [...]
In her inaugural podcast, Jamilee interviews Frank Boehm of NanoApps Medical Inc and NanoApps Athletics Inc. From Jamilee's podcast: Welcome to the first episode of "In a Click". On todays show I chat with [...]
Using straightforward chemistry and a mix-and-match, modular strategy, researchers have developed a simple approach that could produce over 65,000 different types of complex nanoparticles, each containing up to six different materials and eight segments, [...]